home / stock / tbrif / tbrif news

TBRIF News and Press, Therma Bright Inc From 01/31/22

Stock Information
Company Name: Therma Bright Inc
Stock Symbol: TBRIF
Market: OTC
Website: thermabright.com
Menu
TBRIF TBRIF Quote TBRIF Short TBRIF News TBRIF Articles TBRIF Message Board
Get TBRIF Alerts

News, Short Squeeze, Breakout and More Instantly...
TBRIF - Therma Bright Completes U.S. Clinical Performance Study Subject Recruitment

Toronto, Ontario--(Newsfile Corp. - January 31, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, announced today...
TBRIF - Therma Bright Provides Update on U.S. Clinical Performance Study

Toronto, Ontario--(Newsfile Corp. - January 20, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, announced today...

TBRIF - Therma Bright AcuVid(TM) COVID-19 Rapid Antigen Saliva Test's Antibodies Successfully Detect the COVID-19 Omicron B.1.1.529 Variant

Toronto, Ontario--(Newsfile Corp. - December 16, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to confirm that ...

TBRIF - Therma Bright Expands Manufacturing Capabilities To Meet New FDA EUA Guidance For AcuVid(TM)

Agreement with Contract Manufacturer Provides for Production of 500,000 AcuVid(TM) Tests Per Week Toronto, Ontario--(Newsfile Corp. - December 1, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company") , developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva ...
TBRIF - Therma Bright Launches Benepod.com eCommerce Website

The Innovative Hot & Cold Contrast Therapy Device for Relief of Chronic Pain Toronto, Ontario--(Newsfile Corp. - November 24, 2021) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Tes...

TBRIF - Therma Bright to Begin AcuVid(TM) U.S. Clinical Performance Study with Receipt of IRB Conditional Approval

Toronto, Ontario--(Newsfile Corp. - November 12, 2021) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased t...

TBRIF - Therma Bright Provides Update for its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test

Toronto, Ontario--(Newsfile Corp. - October 4, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company and developer of the AcuVid™ Covid-19 Rapid Antigen Saliva Test, provides the following update for its AcuVid TM Covid-19 ...
TBRIF - Therma Bright Successfully Up-lists to the OTCQB Venture Market Under Symbol TBRIF

Provides Update on FDA-EUA Application Process Toronto, Ontario--(Newsfile Corp. - September 14, 2021) -  Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive dia...

TBRIF - Therma Bright Provides Update on FDA-EUA Application Process

Toronto, Ontario--(Newsfile Corp. - September 1, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to provide an upda...

Previous 10 Next 10